(Alliance News) - Hutchmed China Ltd on Monday said Chinese regulators have accepted a new drug application for its cancer treatment fanregratinib and granted it priority review status.

Using electronic health record data from more than 12,000 PBC patients, investigators found that UDCA use was associated with a 41% lower risk of gastrointestinal cancers compared with nonuse (HR 0.59 ...

Fans are sending prayers to Randy Moss after he posted himself in the hospital to commemorate the 1-year anniversary of ...

Moss received an outpouring of support last December when he took time away from his ESPN analyst role to receive treatment ...

Just under a month old, Shaffette had a surgical procedure to connect her liver directly to her small intestine and drain the ...

PLT012, a groundbreaking anti-CD36 antibody, enters clinical trials to enhance immune responses in solid tumors, promising new hope for cancer treatment.

After he died in June from cancer, his wife started a research scholarship in his honor, which will hold a fundraising event ...

Study identifies promising new treatment effective against rare liver disease A new experimental therapy may finally offer ...

Cecilia Shaffette was born in Nov. 23, 2009. Three weeks later, she was rushed into emergency surgery.

PSC occurs in 1 out of 10,000 people, who are mostly male adults between 30 and 60 years old, and it commonly develops in patients with inflammatory bowel disease who have ulcerative colitis. The lack ...

Researchers report promising results for nebokitug, a monoclonal antibody tested for primary sclerosing cholangitis. In a ...